Sage Therapeutics, Inc. with ticker code (SAGE) have now 17 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 105 and 40 suggesting an average Analsyt target price of $60.53. Given that the stocks previous close was at $53.03 this would indicate that there is a potential upside of 14.1%. The 50 day moving average now sits at $46.24 while the 200 day moving average is $41.86. The market capitalization for the company is 3.19B. The current share price for the company is: 53.38 USD
The potential market cap would be $3,641,274,996 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 0.16 and a -24.74% return on assets.
